Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy (Q77888750)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Stereoselective analyses of selegiline metabolites: possible urinary markers for selegiline therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

M Hasegawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

K Matsubara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

S Fukushima

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C Maseda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

T Uezono

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

K Kimura

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

Forensic Science International

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

95-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenil

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

(-) deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Selegiline is neuroprotective in primary brain cultures treated with 1-methyl-4-phenylpyridinium

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

L-(-)-desmethylselegiline, a metabolite of selegiline [L-(-)-deprenyl], protects mesencephalic dopamine neurons from excitotoxicity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Deprenyl is metabolized to methamphetamine and amphetamine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Toxicological detection of selegiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from abu

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Amphetamine: Differentiation by d and l Isomers of Behavior Involving Brain Norepinephrine or Dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Statistical moments in pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

The urinary output of d- and l-amphetamine in man

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Stereochemistry of metabolism of amphetamines: use of (-)-alpha-methoxy-alpha-(trifluoromethyl)phenylacetyl chloride for GLC resolution of chiral amines

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Resolution of methamphetamine stereoisomers in urine drug testing: urinary excretion of R(-)-methamphetamine following use of nasal inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Detection of amphetamine and methamphetamine in urine by gas chromatography/mass spectrometry following derivatization with (-)-menthyl chloroformate

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Pharmacokinetics and relative bioavailability of selegiline in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian properties

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Interpretation of methamphetamine and amphetamine enantiomer data

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

Retrospective analysis of some L-methamphetamine/L-amphetamine urine data

1 reference

https://api.crossref.org/works/10.1016%2FS0379-0738%2899%2900015-8

7 January 2021

10.1016/S0379-0738(99)00015-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10371041%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference